BioLumen logo — Pioneering dietary fiber solutions to support prediabetics i...

BioLumen

Pioneering dietary fiber solutions to support prediabetics in managing blood sugar, liver health, and gut microbiome through innovative nutraceuticals.

Founded 2018 11-50 employees Convertible Note Biotechnology, Health Care +3

General Information

Company Name BioLumen
Founded Year 2018
Employees 11-50
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with BioLumen. To contact BioLumen, visit biolumen.tech.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioLumen compare?

A PDF of BioLumen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioLumen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioLumen

BioLumen, founded in 2018 and based in San Francisco, California, is a nutritional technology company that focuses on pioneering dietary fiber solutions for prediabetics. Their patented technology, comprising an insoluble dietary fiber matrix coated with a carefully crafted blend of food ingredients, stems from advanced drug delivery system research. The company's flagship product, a nutraceutical, is designed to assist individuals at high risk for prediabetes by managing blood sugar levels, protecting the liver from excess sugar, and nourishing the gut microbiome, thus providing significant health benefits. With a focus on Biotechnology, Health Care, Health and Wellness, Nutrition, and Pharmaceutical industries, BioLumen secured a Convertible Note investment on 24 June 2022 from SOSV and indiebio.

Business keywords: nutritional technology, dietary fiber, prediabetes management, nutraceuticals, blood sugar, liver health, gut microbiome, patented technology, insoluble dietary fiber, advanced drug delivery system, San Francisco, processed foods

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 2
SOSV, indiebio
24 Jun 2022
Seed Round Undisclosed 1
Embryo Ventures
15 Apr 2021
Seed Round Undisclosed 2
SOSV, indiebio
05 Nov 2019

BioLumen Alternatives & Competitors

View All Alternatives
BioLumen vs

Unlocking the potential for a better life

24 employees
Biotechnology, Health Care
BioLumen vs
Artgerecht
Artgerecht Germany

Evolution is our solution.

26 employees
E-Commerce, Health Care
BioLumen vs
Xbiome
Xbiome United States

China's leading AI-driven microbiome drug development company

Series B
51 employees
AI, Biotechnology

FAQ About BioLumen

Pioneering dietary fiber solutions to support prediabetics in managing blood sugar, liver health, and gut microbiome through innovative nutraceuticals.
BioLumen was founded in 2018.
BioLumen operates in Biotechnology, Health Care, Health and Wellness, Nutrition and Pharmaceutical. Its work centres on nutritional technology, dietary fiber, prediabetes management and nutraceuticals.
BioLumen has approximately 11-50 employees.
BioLumen has completed 3 funding rounds. The latest funding stage is Convertible Note.
Top alternatives and competitors to BioLumen include Medlab Clinical Ltd, Artgerecht, Xbiome, Leckar Botanicals, Efficas, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioLumen and Medlab Clinical Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioLumen, https://bouncewatch.com/company/biolumen, updated 2 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes